主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Gao Wei1 Gao Yang1 Sun Lu2 Liu Shuang1
单位:1首都医科大学附属北京安贞医院呼吸与危重症医学科100029;2华中科技大学同济医学院附属协和医院西院综合科,武汉430000
英文单位:1Department of Respiratory and Critical Care Medicine Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 2Department of Comprehensive West Hospital of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan 430000 China
关键词:新型冠状病毒肺炎;下肢深静脉血栓形成;Padua预测评分表
英文关键词:Coronavirusdisease-19;Deepvenousthrombosis;Paduaforecastscoretable
目的 探讨Padua预测评分表评估新型冠状病毒肺炎(COVID-19)患者下肢深静脉血栓形成(DVT)风险的有效性。方法入选2020年2月11日至3月22日华中科技大学同济医学院附属协和医院西院确诊COVID-19的212例患者,住院时间>1周,D二聚体升高≥正常值上限2倍。用Padua预测评分表评估,对46例评分≥4分的DVT高危患者进行床旁下肢血管超声检查,分析DVT各部位发生率,根据是否发生DVT分为DVT组(22例)和非DVT组(24例)。分析2组Padua分值差异,Padua评分与血栓危险分级的关系及其对COVID-19患者DVT的诊断价值。结果212例初步入选患者中,有46例(21.7%)患者Padua评分≥4分,其中22例(47.8%)超声诊断合并DVT,共54处,以腓肠肌静脉和胫后静脉为主,分别占59.3%(32/54)和22.2%(12/54)。CMH检验结果显示,Padua评分分值与DVT发生风险显著相关,组间差异有统计学意义(χ2=19.00,P<0.01)。Padua评分≥6分预测COVID-19患者发生DVT的受试者工作特征曲线下面积为0.938,敏感度为63.6%,特异度为95.8%,诊断约登指数为0.595。结论对COVID-19患者,Padua预测评分表可以有效进行血栓危险分级。Padua评分≥6分对诊断COVID-19患者DVT有较高的特异性。
ObjectiveTo investigate the validity of Padua forecast score table in assessment the risk of deep venous thrombosis(DVT) of patients with corona virus disease-19(COVID-19). Methods From February 11 to March 22 ,2020totally 212 patients diagnosed with COVID-19 admitted to West Hospital of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology were selected. All patients stayed in hospital for more than 1 week, and D-dimer increased by more than or equal to 2 times the upper limit of normal.Forty-six patients with high risk of DVT with Padua prediction score ≥4 were examined by bedside vascular ultrasound T he incidence of various parts of DVT was analyzed. Forty-six patients were divided into DVT group (22 cases) and non-DVT group (24 cases).The difference of Padua score ,the relationship between Padua score and thrombus risk classification, as well as the diagnostic value of Padua score for DVT in COVID-19 patients were analyzed.Results Among 212 primary patients, there were 46 patients(21.7%) with Padua predictive score ≥ 4 and 22cases(47.8%) were diagnosed with DVT by ultrasound in total 54 sites. Thrombosis were mainly in gastrocnemius vein and the posterior tibial vein accounting to 59.3%(32/54) and 22.2%(12/54), respectively. The results of CMH test showed that Padua score was significantly related to the risk of DVT(χ2=19.00, P<0.01). The area under the receiver operator characteristic curve predicting DVT occurrence in COVID-19 patients by Padua predictive score≥6 was 0.938, the diagnostic Youden′s index was 0.595, with 63.6% sensitivity and 95.8% specificity. Conclusions For COVID-19 patients, the Padua forecast score table would be effective for thromboembolism risk classification. Padua score ≥ 6 is highly specific for the diagnosis of DVT in COVID-19 patients.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。